Terms: = Ovarian cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO
99 results:
1. The Gustave Roussy immune score as a novel scoring system for predicting platinum resistance in advanced high-grade serous ovarian cancer.
Nie X; Xu T; Zhang L; Cheng W
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():97-104. PubMed ID: 38219610
[TBL] [Abstract] [Full Text] [Related]
2. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
Chandy RG; Thomas V; Sebastian A; Mani T; Thomas A; Joel A; Ram TS; Peedicayil A
Indian J Cancer; 2023 Oct; 60(4):475-485. PubMed ID: 38185864
[TBL] [Abstract] [Full Text] [Related]
3. The use of fertility treatments among reproductive-aged women after cancer.
Kipling LM; Shandley LM; Mertens AC; Spencer JB; Howards PP
Fertil Steril; 2024 Apr; 121(4):578-588. PubMed ID: 38103881
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia promotes the growth and metastasis of ovarian cancer cells by suppressing ferroptosis via upregulating SLC2A12.
Li M; Li L; Cheng X; Li L; Tu K
Exp Cell Res; 2023 Dec; 433(2):113851. PubMed ID: 37940066
[TBL] [Abstract] [Full Text] [Related]
5. Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis.
Gong W; Yu R; Cao C; Fang Y; Zhao X; Gao Q
J Ovarian Res; 2023 Jul; 16(1):136. PubMed ID: 37430376
[TBL] [Abstract] [Full Text] [Related]
6. Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: A randomized controlled clinical trial.
Yang X; Chai M; Xia L; He Z; Wu X; Zhang J
Acta Obstet Gynecol Scand; 2023 Jul; 102(7):950-959. PubMed ID: 37029431
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
8. Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations.
Yuan S; Chen J; Ruan X; Vithayathil M; Kar S; Li X; Mason AM; Burgess S; Larsson SC
Arthritis Res Ther; 2022 Dec; 24(1):270. PubMed ID: 36514134
[TBL] [Abstract] [Full Text] [Related]
9. Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Kazemi MH; Sadri M; Najafi A; Rahimi A; Baghernejadan Z; Khorramdelazad H; Falak R
Front Immunol; 2022; 13():1018962. PubMed ID: 36389779
[TBL] [Abstract] [Full Text] [Related]
10. Multi-Institutional Review of the Preoperative Diagnostic Accuracy for Pediatric ovarian Mature Cystic Teratomas.
Knaus ME; Onwuka AJ; Afrazi A; Breech L; Corkum KS; Dillon PA; Ehrlich PF; Fallat ME; Fraser JD; Gadepalli SK; Grabowski JE; Hertweck SP; Kabre R; Lal DR; Landman MP; Lawrence AE; Leys CM; Mak GZ; Markel TA; Merchan N; Overman RE; Rademacher BL; Raiji MT; Rymeski B; Sato TT; Scannel M; Schikler AG; Sujka JA; Wright T; Aldrink JH; Hewitt GD; Minneci PC; Deans KJ;
J Pediatr Adolesc Gynecol; 2022 Aug; 35(4):478-485. PubMed ID: 35124214
[TBL] [Abstract] [Full Text] [Related]
11. Effects of Gonadotropin-Releasing Hormone Analogs on ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast cancer in China: A Randomized Clinical Trial.
Zong X; Yu Y; Yang H; Chen W; Ding X; Liu S; Li X; Chen X; Jiang C; Xia X; Huang R; Zhu M; Hu J; Liang C
JAMA Oncol; 2022 Feb; 8(2):252-258. PubMed ID: 34967844
[TBL] [Abstract] [Full Text] [Related]
12. ovarian Cystadenomas: Growth Rate and Reliability of Imaging Measurements.
Suh-Burgmann E; Nakhaei M; Gupta S; Brook A; Hecht J; Hung YY; Levine D
J Ultrasound Med; 2022 Sep; 41(9):2157-2167. PubMed ID: 34846072
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis.
Inzani F; Santoro A; Travaglino A; D'Alessandris N; Raffone A; Straccia P; Angelico G; Arciuolo D; Scaglione G; Valente M; Tralongo P; Gallotta V; Zannoni GF
Arch Gynecol Obstet; 2022 Aug; 306(2):315-321. PubMed ID: 34799743
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Characterization of Peritoneal Involvement in Primary Colon and Ovary Neoplasm: The Possible Clinical Meaning of the P2X7 Receptor-Inflammasome Complex.
Solini A; Cobuccio L; Rossi C; Parolini F; Biancalana E; Cosio S; Chiarugi M; Gadducci A
Eur Surg Res; 2022; 63(3):114-122. PubMed ID: 34758468
[TBL] [Abstract] [Full Text] [Related]
15. Analysis on clinical association of uterine scar diverticulum with subsequent infertility in patients underwent cesarean section.
Bi B; Gao S; Ruan F; Shi Y; Jiang Y; Liu S; Lv W
Medicine (Baltimore); 2021 Oct; 100(41):e27531. PubMed ID: 34731147
[TBL] [Abstract] [Full Text] [Related]
16. Gemogenovatucel-T (Vigil) maintenance immunotherapy: 3-year survival benefit in homologous recombination proficient (HRP) ovarian cancer.
Walter A; Rocconi RP; Monk BJ; Herzog TJ; Manning L; Bognar E; Wallraven G; Aaron P; Horvath S; Tang M; Stanbery L; Coleman RL; Nemunaitis J
Gynecol Oncol; 2021 Dec; 163(3):459-464. PubMed ID: 34702567
[TBL] [Abstract] [Full Text] [Related]
17. Resilience: a mediator of the negative effects of pandemic-related stress on women's mental health in the USA.
Kumar S; Lee NK; Pinkerton E; Wroblewski KE; Lengyel E; Tobin M
Arch Womens Ment Health; 2022 Feb; 25(1):137-146. PubMed ID: 34651237
[TBL] [Abstract] [Full Text] [Related]
18. A human antibody against human endothelin receptor type A that exhibits antitumor potency.
Ju MS; Ahn HM; Han SG; Ko S; Na JH; Jo M; Lim CS; Ko BJ; Yu YG; Lee WK; Kim YJ; Jung ST
Exp Mol Med; 2021 Sep; 53(9):1437-1448. PubMed ID: 34588605
[TBL] [Abstract] [Full Text] [Related]
19. [Analysis of perioperative complications and influencing factors of complications in 1 000 cases of robotic gynecological surgery].
Huang XT; Ji M; Zhao Z; He NN; Li Y; Xu PL; Zhang JF
Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):341-348. PubMed ID: 34034421
[No Abstract] [Full Text] [Related]
20. Determination of Potential Therapeutic Targets and Prognostic Markers of ovarian cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract] [Full Text] [Related]
[Next]
